Giuseppe Ciaramella, President & CSO at Beam Therapeutics Inc. (BEAM), sold 102,030 shares at $43.15 ($4.4M) on 2022-12-12, disclosed to the SEC on 2022-12-14.
Open-market sale of $4.4M BEAM by President & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.30 | 31,699 | $1.3M | 30.8% |
| 2 | $42.30 | 31,699 | $1.3M | 30.8% |
| 3 | $43.15 | 13,933 | $601K | 13.8% |
| 4 | $43.15 | 13,933 | $601K | 13.8% |
| 5 | $43.87 | 5,383 | $236K | 5.4% |
| 6 | $43.87 | 5,383 |
| $236K |
| 5.4% |
| Total | $42.70 avg | 102,030 | $4.4M | 100% |
| Filing → |
| BEAM | SELL | 2025-04-03 | $273K | — | Filing → |
| BEAM | SELL | 2024-11-08 | $2.7M | — | Filing → |
| BEAM | SELL | 2024-10-16 | $2.7M | — | Filing → |